Edition:
United Kingdom

Resverlogix Corp (RVX.TO)

RVX.TO on Toronto Stock Exchange

2.76CAD
16 Aug 2019
Change (% chg)

$0.02 (+0.73%)
Prev Close
$2.74
Open
$2.80
Day's High
$2.80
Day's Low
$2.74
Volume
21,975
Avg. Vol
108,134
52-wk High
$4.94
52-wk Low
$2.62

About

Resverlogix Corp is Canada-based clinical-stage biotechnology company. The Company is developing apabetalone (RVX-208), a molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is the BET inhibitor... (more)

Overall

Beta: 0.86
Market Cap(Mil.): $577.46
Shares Outstanding(Mil.): 204.13
Dividend: --
Yield (%): --

Financials

  RVX.TO Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -0.77 -- --
ROI: -- 7.52 12.69
ROE: -- 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates